We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.
...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.
Genome editing (or gene editing) is a group of technologies that allow scientists to change an organism's DNA, by removing, altering, or adding to specific locations in the genome.
Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.
Altasciences is expanding its current clinical operations in Montreal and Kansas City with the addition of a clinical CRO on the U.S.A.'s West Coast. Click below to read more about the acquisition of WCCT Global.